急性缺血性脑卒中溶栓治疗

被引:36
作者
卢晓喆
黄延焱
机构
[1] 复旦大学附属华山医院老年病科
关键词
卒中; 脑缺血; 组织型纤溶酶原激活物; 抗凝药; 血小板聚集抑制剂; 血小板膜糖蛋白类;
D O I
暂无
中图分类号
R743.3 [急性脑血管疾病(中风)];
学科分类号
1002 ;
摘要
<正>在过去的20年里,全球的年龄标化脑卒中病死率有所下降,但每年发生脑卒中的患者、脑卒中相关死亡和脑卒中的全球总负担的绝对数量巨大,而且仍在增加。脑卒中已成为我国城市和农村人口第一位致残和死亡原因,其中缺血性脑卒中占70%。在目前全球各国制定的指南中,静脉注射重组组织型纤溶酶原激活剂(rt-PA)标准剂量0.9mg/kg的治疗被推荐为缺血性脑卒中急性期的标准治疗方案。1静脉溶栓治疗的现状
引用
收藏
页码:1230 / 1232
页数:3
相关论文
共 12 条
[1]  
Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial[J] . Colin P Derdeyn,Marc I Chimowitz,Michael J Lynn,David Fiorella,Tanya N Turan,L Scott Janis,Jean Montgomery,Azhar Nizam,Bethany F Lane,Helmi L Lutsep,Stanley L Barnwell,Michael F Waters,Brian L Hoh,J Maurice Hourihane,Elad I Levy,Andrei V Alexandrov,Mark R Harrigan,David Chiu,Richard P Klucznik,Joni M Clark,Cameron G McDougall,Mark
[2]  
Third International Stroke Trial 3: an update[J] . Antonio Arauz,Eivind Berge,Peter Sandercock.Current Opinion in Neurology . 2014 (1)
[3]  
Combining Statins with Tissue Plasminogen Activator Treatment After Experimental and Human Stroke: A Safety Study on Hemorrhagic Transformation[J] . Mireia Campos,Lidia García‐Bonilla,Mar Hernández‐Guillamon,Verónica Barceló,Anna Morancho,Manolo Quintana,Marta Rubiera,Anna Rosell,Joan Montaner.CNS Neurosci Ther . 2013 (11)
[4]   Intravenous Tissue Plasminogen Activator Administration in Community Hospitals Facilitated by Telestroke Service [J].
Chalouhi, Nohra ;
Dressler, Jeremy A. ;
Kunkel, Emily S. I. ;
Dalyai, Richard ;
Jabbour, Pascal ;
Gonzalez, L. Fernando ;
Starke, Robert M. ;
Dumont, Aaron S. ;
Rosenwasser, Robert ;
Tjoumakaris, Stavropoula .
NEUROSURGERY, 2013, 73 (04) :667-671
[5]  
Combined Approach to Lysis Utilizing Eptifibatide and Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke–Enhanced Regimen Stroke Trial[J] . Arthur M. Pancioli,Opeolu Adeoye,Pamela A. Schmit,Jane Khoury,Steven R. Levine,Thomas A. Tomsick,Heidi Sucharew,Claudette E. Brooks,Todd J. Crocco,Laurie Gutmann,Thomas M. Hemmen,Scott E. Kasner,Dawn Kleindorfer,William A. Knight,Sharyl Martini,James S. McKinney,William J. Meurer,Brett C. Meyer,Alexander Schneider,Phillip A. Scott,Sidney Stark
[6]  
Impact of Telemedicine Implementation in Thrombolytic Use for Acute Ischemic Stroke: The University of Pittsburgh Medical Center Telestroke Network Experience[J] . Edilberto Amorim,Min-Mei Shih,Steven A. Koehler,Lori L. Massaro,Syed F. Zaidi,Mouhammad A. Jumaa,Vivek K. Reddy,Maxim D. Hammer,Tudor G. Jovin,Lawrence R. Wechsler.Journal of Stroke and Cerebrovascular Diseases . 2013 (4)
[7]  
Pooled Assessment of Computed Tomography Interpretation by Vascular Neurologists in the STRokE DOC Telestroke Network[J] . Ilana Spokoyny,Rema Raman,Karin Ernstrom,Bart M. Demaerschalk,Patrick D. Lyden,Thomas M. Hemmen,Amy K. Guzik,James Y. Chen,Brett C. Meyer.Journal of Stroke and Cerebrovascular Diseases . 2013
[8]  
Improving Door-to-Needle Times in Acute Ischemic Stroke: The Design and Rationale for the American Heart Association/American Stroke Association?s Target: Stroke Initiative[J] . Gregg C. Fonarow,Eric E. Smith,Jeffrey L. Saver,Mathew J. Reeves,Adrian F. Hernandez,Eric D. Peterson,Ralph L. Sacco,Lee H. Schwamm.Stroke . 2011 (10)
[9]   Stroke Treatment Academic Industry Roundtable (STAIR) Recommendations for Maximizing the Use of Intravenous Thrombolytics and Expanding Treatment Options With Intra-arterial and Neuroprotective Therapies [J].
Albers, Gregory W. ;
Goldstein, Larry B. ;
Hess, David C. ;
Wechsler, Lawrence R. ;
Furie, Karen L. ;
Gorelick, Philip B. ;
Hurn, Patty ;
Liebeskind, David S. ;
Nogueira, Raul G. ;
Saver, Jeffrey L. .
STROKE, 2011, 42 (09) :2645-2650
[10]  
DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4·5 h of symptom onset (PRE-FLAIR): a multicentre observational study[J] . Lancet Neurology . 2011 (11)